Skip to main content

Table 3 Univariate and multivariate analyses of predictive factors for survival of ovarian cancer patients

From: Mucinous, endometrioid, and serous ovarian cancers with peritoneal dissemination are potent candidates for P-cadherin targeted therapy: a retrospective cohort study

Factors n Disease-free survival Overall survival
Univariate
P-value
Multivariate Univariate
P-value
Multivariate
HR 95%CI P-value HR 95%CI P-value
Age a (years)   .187     .176    
  ≤ 55 79         
  > 55 83         
CA125a   6.3e-4* 2.29 1.08–4.84 .030* .0017* 2.31 1.10–4.84 .027*
  ≤136 79         
  > 136 81         
Stageb (FIGO2014) 1.0e-7* 3.40 1.32–8.80 .011* 4.9e-7* 4.03 1.53–10.6 .0048*
  Stage I/II 88         
  Stage III/IV 74         
Peritoneal dissemination 5.0e-8* 4.06 1.42–11.6 .0090* 2.5e-6* 2.94 1.03–8.38 .044*
  Positive 76         
  Negative 86         
Lymph node metastasis .091     .109    
  Positive 24         
  Negative 138         
Distant site metastasis .062     .095    
  Positive 10         
  Negative 152         
Histologic typeb   .014* 0.42 0.20–0.92 .029* .030* 0.42 0.19–0.93 .032*
  Serous 75         
  Others 87         
P-cadherin   .058 1.18 0.56–2.49 .669 .050 1.19 0.55–2.58 .653
  High 95         
  Low 67         
  1. Univariate and multivariate analyses of predictive factors for survival in ovarian cancer patients
  2. *P < 0.05. aCutoff value as the median value. bPathological diagnosis. CI confidence interval; HR hazard ratio